Key Insights

Highlights

Success Rate

93% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

3.2%

1 terminated out of 31 trials

Success Rate

92.9%

+6.4% vs benchmark

Late-Stage Pipeline

3%

1 trials in Phase 3/4

Results Transparency

23%

3 of 13 completed with results

Key Signals

3 with results93% success

Data Visualizations

Phase Distribution

20Total
Not Applicable (12)
P 1 (2)
P 2 (5)
P 4 (1)

Trial Status

Completed13
Not Yet Recruiting6
Recruiting5
Unknown4
Terminated1
Withdrawn1

Trial Success Rate

92.9%

Benchmark: 86.5%

Based on 13 completed trials

Clinical Trials (31)

Showing 20 of 20 trials
NCT06117176Recruiting

Prospective Assessment Project of AirwaY Management-related Incidents in Adult Anaesthesia Care PAPAYA III

NCT07024238Not ApplicableEnrolling By Invitation

Impact of SCFA Supplementation on Gut Microbiome Composition of Kidney Transplant Recipients

NCT06951581Not ApplicableCompleted

Impact of SCFA Supplementation on Metabolic Profiles in Serum and Urine of Kidney Transplant Recipients.

NCT05804188Recruiting

CRICKET: Critical Events in Anaesthetised Kids Undergoing Tracheal Intubation

NCT06929637Not ApplicableNot Yet Recruiting

Amino Acid Infusion in Kidney Transplant Recipients

NCT05038527Not ApplicableRecruiting

ABM/P-15 Bone Graft vs Traditional Bone Graft in Adult Spinal Deformity Surgery

NCT06891521Phase 2Not Yet Recruiting

Electroacupuncture for Preventing Adverse Events of Cancer Immunotherapy

NCT06890091Not Yet Recruiting

Study of the Association Between Fatigue Experienced by Patients and the Specific Side Effects of CART Cells, During the First Month After Administration for Non-Hodgkin's Lymphoma

NCT06733701Not ApplicableNot Yet Recruiting

The Use of Virtual Reality Technology During Oocyte Retrieval for in Vitro Fertilization

NCT06684054Not Yet Recruiting

Studying the Senescent T Cell Features and Its Relationship with the Chemotherapy Efficacy in Young TNBC

NCT06636422Not Yet Recruiting

Post-marketing Safety and Efficacy Surveillance of Motherwort Injection

NCT02011607Terminated

Incidence of Adverse Airway Events in High Risk Patients Undergoing Upper GI Endoscopy Under Anesthesia

NCT05359666Not ApplicableCompletedPrimary

Retrospective Independent Safety Review of Closed Irrisept Study

NCT05815615Not ApplicableCompleted

Plasmapheresis: a Multi-modal Approach

NCT05709392Not ApplicableRecruiting

Preterm DElayed Cord Clamping and Early Skin-to-Skin Contact: PreDECESS

NCT00580489Not ApplicableCompleted

Lifeflight: Fentanyl Versus Morphine

NCT05390125UnknownPrimary

Effectiveness of a Proficiency-based Progression Communication Training Programme

NCT05311566Phase 2Recruiting

PD-1 Antibody Plus Chemoradiotherapy for IB2-IIIB Cervical Cancer

NCT05311579Phase 2Unknown

Niraparib Plus Anlotinib for Recurrent Ovarian Cancer

NCT05310344Phase 2Unknown

Albumin-bound Paclitaxel and Bevacizumab for Platinum-resistant Recurrent Ovarian Cancer

Scroll to load more

Research Network

Activity Timeline